A single center experience: rituximab plus cladribine is an effective and safe first-line therapy for unresectable bronchial-associated lymphoid tissue lymphoma.
about
A single center experience: rituximab plus cladribine is an effective and safe first-line therapy for unresectable bronchial-associated lymphoid tissue lymphoma.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
A single center experience: ri ...... ated lymphoid tissue lymphoma.
@ast
A single center experience: ri ...... ated lymphoid tissue lymphoma.
@en
type
label
A single center experience: ri ...... ated lymphoid tissue lymphoma.
@ast
A single center experience: ri ...... ated lymphoid tissue lymphoma.
@en
prefLabel
A single center experience: ri ...... ated lymphoid tissue lymphoma.
@ast
A single center experience: ri ...... ated lymphoid tissue lymphoma.
@en
P2093
P2860
P356
P1476
A single center experience: ri ...... ated lymphoid tissue lymphoma.
@en
P2093
P2860
P304
P356
10.21037/JTD.2017.03.81
P577
2017-04-01T00:00:00Z